The status is typically determined using immunohistochemistry (IHC) techniques. In this method, antibodies specific to estrogen receptor (ER) and progesterone receptor (PR) proteins are applied to tissue sections. The binding of these antibodies is then visualized using various staining methods. The presence and intensity of the staining indicate the receptor status.
